Literature DB >> 27639768

Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.

Ting Deng1, Yaozong Yuan, Chunni Zhang, Chenyu Zhang, Weiyan Yao, Cheng Wang, Rui Liu, Yi Ba.   

Abstract

BACKGROUND: The aim of this study was to identify novel microRNAs for potential use in the diagnosis of pancreatic cancer (PaC).
METHODS: A total of 1063 serum samples from 303 patients with PaC were collected, and the expression level of miR-25 was measured using quantitative real-time PCR (qRT-PCR).
RESULTS: We found that miR-25 had significant diagnostic value for the differential diagnosis of PaC in normal controls with an AUC (the area under the ROC curve) of 0.915 (95% CI: 0.893-0.937) that was significantly higher compared with an AUC of 0.725 for serum tumor marker carcinoembryonic antigen (CEA) and an AUC of 0.844 for CA19-9.
CONCLUSIONS: These data suggest that serum miR-25 has strong potential as a novel biomarker for the early detection of PaC.
© 2016 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27639768     DOI: 10.1159/000447872

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  20 in total

1.  Diagnostic Value of Plasma miR-181b, miR-196a, and miR-210 Combination in Pancreatic Cancer.

Authors:  Gongpan Liu; Cunhua Shao; Anyun Li; Xiaobin Zhang; Xingjun Guo; Jiangong Li
Journal:  Gastroenterol Res Pract       Date:  2020-08-06       Impact factor: 2.260

2.  miR-25 expression is upregulated in pancreatic ductal adenocarcinoma and promotes cell proliferation by targeting ABI2.

Authors:  Huimin Lu; Ling Zhang; Shan Lu; Dujiang Yang; Jun Ye; Mao Li; Weiming Hu
Journal:  Exp Ther Med       Date:  2020-03-11       Impact factor: 2.447

3.  Validation of Biomarkers for Early Detection of Pancreatic Cancer: Summary of The Alliance of Pancreatic Cancer Consortia for Biomarkers for Early Detection Workshop.

Authors:  Matthew R Young; Paul D Wagner; Sharmistha Ghosh; Jo Ann Rinaudo; Stuart G Baker; Kenneth S Zaret; Michael Goggins; Sudhir Srivastava
Journal:  Pancreas       Date:  2018-02       Impact factor: 3.327

4.  Biomarkers of Chronic Pancreatitis: A systematic literature review.

Authors:  Zobeida Cruz-Monserrate; Kristyn Gumpper; Valentina Pita; Phil A Hart; Christopher Forsmark; David C Whitcomb; Dhiraj Yadav; Richard T Waldron; Stephen Pandol; Hanno Steen; Vincent Anani; Natasha Kanwar; Santhi Swaroop Vege; Savi Appana; Liang Li; Jose Serrano; Jo Ann S Rinaudo; Mark Topazian; Darwin L Conwell
Journal:  Pancreatology       Date:  2021-01-22       Impact factor: 3.996

Review 5.  Alterations of Epigenetic Regulators in Pancreatic Cancer and Their Clinical Implications.

Authors:  Brittany R Silverman; Jiaqi Shi
Journal:  Int J Mol Sci       Date:  2016-12-19       Impact factor: 5.923

Review 6.  Clinical utilization of serum- or plasma-based miRNAs as early detection biomarkers for pancreatic cancer: A meta-analysis up to now.

Authors:  Lunshou Wei; Kunhou Yao; Shibao Gan; Zhimin Suo
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Bayesian multilevel model of micro RNA levels in ovarian-cancer and healthy subjects.

Authors:  Paweł Wiczling; Emilia Daghir-Wojtkowiak; Roman Kaliszan; Michał Jan Markuszewski; Janusz Limon; Magdalena Koczkowska; Maciej Stukan; Alina Kuźniacka; Magdalena Ratajska
Journal:  PLoS One       Date:  2019-08-29       Impact factor: 3.240

8.  Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review.

Authors:  Jinru Xue; Erna Jia; Na Ren; Andrew Lindsay; Haixin Yu
Journal:  Onco Targets Ther       Date:  2019-08-19       Impact factor: 4.147

Review 9.  Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.

Authors:  Wanqing Weng; Zhongjing Zhang; Weiguo Huang; Xiangxiang Xu; Boda Wu; Tingbo Ye; Yunfeng Shan; Keqing Shi; Zhuo Lin
Journal:  Cancer Cell Int       Date:  2020-06-11       Impact factor: 5.722

10.  Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma.

Authors:  Xiaojiao Li; Meijiao Qin; Jiacheng Huang; Jie Ma; Xiaohua Hu
Journal:  Mol Med Rep       Date:  2019-04-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.